Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Akero Therapeutics to Present Preliminary Topline Week 96 Results from Phase 2b SYMMETRY Study Investigating Efruxifermin in Patients with Compensated Cirrhosis (F4) Due to MASH
January 24, 2025 16:05 ET | Source: Akero Therapeutics Inc. Investor webcast…
Disc Medicine to Host Conference Call on Type C Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)
January 20, 2025 19:00 ET | Source: Disc Medicine Inc WATERTOWN, Mass.,…
New Book “Prescribed Malnutrition: An Oncology Nutrition Narrative Review” Announces Critical Insights into Cancer Nutrition Misconceptions
Challenging Cancer Diet Myths: 'Prescribed Malnutrition' Unpacks the Science Behind Oncology Nutrition…
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
Transaction Expected to Close in the Coming DaysSOMERSET, N.J. & COPENHAGEN, Denmark--(BUSINESS…
The Esthetic Clinics Attracts 15% Global Patients to India, Amid Cosmetic Surgery Medical Tourism Boom: MedTalks News
MUMBAI, India, Dec. 13, 2024 /PRNewswire/ -- MedTalks News features The Esthetic Clinics®…
Monopar Announces First Patient Dosed with its Novel Therapeutic Radiopharmaceutical MNPR-101-Lu
WILMETTE, Ill., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq:…
Vevo Therapeutics Partners with the Parse Biosciences GigaLab to Generate 100M Cell Atlas for AI Powered Drug Discovery
SEATTLE--(BUSINESS WIRE)--Parse Biosciences, a leading provider of accessible and scalable single cell…
MEDSIR, Featured Company at the Shanghai International Medical Oncology Symposium (7th SIMOS)
MEDSIR, a leader in independent clinical research in oncology, strengthens its commitment…
Derm-Biome Pharmaceuticals adds Dr. Jerry Tan, internationally renowned expert in acne and acne scarring, to its Scientific Advisory Board
VANCOUVER, British Columbia, Nov. 25, 2024 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc,…